# Erwinase Master Treatment Protocol

> **NCT00590915** · — · NO_LONGER_AVAILABLE · sponsor: **Phoenix Children's Hospital**

## Conditions studied

- Leukemia, Acute Lymphoblastic
- Acute Lymphoid Leukemia

## Interventions

- **DRUG:** Erwinia L-asparaginase

## Key facts

- **NCT ID:** NCT00590915
- **Lead sponsor:** Phoenix Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-01-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590915, "Erwinase Master Treatment Protocol". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00590915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*